Perrigo | PRGO - Interest Expense On Debt


Perrigo reported $7.98B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Abbott USD 68M 26M Mar/2026
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
Coherus Biosciences USD 2.25M 76K Dec/2025
Corcept Therapeutics USD 814.88M 809.46M Mar/2026
Dr.Reddys Laboratories INR 1.06B 113M Mar/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
J&J USD 43M 25M Mar/2026
Merck USD 479M 67M Mar/2026
Nestle CHF 897M 32M Dec/2025
Pacira USD 3.7M 193K Mar/2026
Perrigo USD 7.98B 7.94B Mar/2026
Pfizer USD 671M 40M Mar/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Reckitt Benckiser GBP 208M 198.3M Dec/2024
Sanofi EUR 178M 203M Mar/2026
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 216M 4M Mar/2026
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025
Zoetis USD 62M 5M Mar/2026